Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

83.99

+3.55 (4.41%)

At close: Jul 2, 2026, 4:00 PM EDT

83.90

-0.09 (-0.11%)

After-hours: Jul 2, 2026, 7:46 PM EDT

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 2, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Cap	11,831	4,680	2,409	2,883	3,502	6,513
Market Cap Growth	452.68%	94.27%	-16.45%	-17.66%	-46.23%	47.75%
Enterprise Value	11,432	4,653	2,615	2,879	3,227	6,171
Last Close Price	83.99	34.49	19.37	26.87	33.05	62.43
PS Ratio	19.02	5.64	678.45	11.98	14.40	47.10
PB Ratio	19.23	10.10	13.19	10.63	8.79	15.93
P/TBV Ratio	19.24	10.02	12.88	10.99	9.01	16.39
P/FCF Ratio	-	29.83	-	-	-	44.08
P/OCF Ratio	-	26.07	-	-	-	38.02
EV/Sales Ratio	18.38	5.61	736.40	11.96	13.27	44.62
EV/EBITDA Ratio	-	38.06	-	-	-	-
EV/EBIT Ratio	-	47.32	-	-	-	-
EV/FCF Ratio	-	29.66	-	-	-	41.77
Debt / Equity Ratio	2.28	1.44	4.43	1.30	0.19	0.06
Debt / EBITDA Ratio	-	6.00	-	-	-	-
Debt / FCF Ratio	-	4.68	-	-	-	0.17
Net Debt / Equity Ratio	2.00	-0.10	1.08	-0.07	-0.74	-0.84
Net Debt / EBITDA Ratio	-6.24	-0.39	-0.34	0.11	1.75	2.43
Net Debt / FCF Ratio	-24.09	-0.30	-0.33	0.06	1.56	-2.32
Asset Turnover	0.32	0.66	0.00	0.33	0.35	0.22
Quick Ratio	0.55	4.02	6.34	3.83	2.72	2.58
Current Ratio	6.23	4.86	6.74	3.95	2.92	2.62
Return on Equity (ROE)	-46.81%	8.67%	-254.98%	-59.33%	-42.67%	-32.36%
Return on Assets (ROA)	-12.35%	4.55%	-62.81%	-28.51%	-26.02%	-24.18%
Return on Invested Capital (ROIC)	-15.92%	13.60%	-182.56%	-106.40%	-191.92%	-127.38%
Return on Capital Employed (ROCE)	-13.74%	8.83%	-70.85%	-33.80%	-31.97%	-28.51%
FCF Yield	-	3.35%	-	-	-	2.27%
Buyback Yield / Dilution	-9.83%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%
Total Shareholder Return	-9.83%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%

SEC Filings: 10-K · 10-Q